Systemic Lupus Erythematosus-associated Thrombocytopenia in Pregnancy: Is Splenectomy Necessary at the Time of Delivery?

Authors

M Granate
F Quaglia
Patrizio Petrone, New York Medical CollegeFollow
G Cerciello
Corrado Marini, New York Medical CollegeFollow
P Martinelli

Journal Title

Panamerican Journal of Trauma, Critical Care & Emergency Surgery

First Page

219

Last Page

223

Document Type

Article

Publication Date

9-1-2017

Department

Surgery

Abstract

Systemic lupus erythematosus (SLE)-associated thrombocytopenia in pregnancy is a rare condition associated with potential harm to the mother, the fetus, and/or newborn, if the thrombocytopenia is severe (<50,000/mm3). Controversy persists regarding the role and the timing of splenectomy in patients with SLE-associated refractory immune thrombocytopenia in pregnancy. This report describes the use of splenectomy at the time of the cesarean section (CS) in a patient with refractory SLE-associated thrombocytopenia.

Recommended Citation

Granate, M., Quaglia, F., Petrone, P., Cerciello, G., Marini, C., & Martinelli, P. (2017). Systemic Lupus Erythematosus-associated Thrombocytopenia in Pregnancy: Is Splenectomy Necessary at the Time of Delivery?. Panamerican Journal of Trauma, Critical Care & Emergency Surgery, 6 (3), 219-223. https://doi.org/10.5005/jp-journals-10030-1195

Publisher's Statement

Originally published in Panamerican Journal of Trauma, Critical Care & Emergency Surgery, 6(3), 219-223. The original material can be found here.